Shanghai, China

Wenhua Ji


 

Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2013

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Wenhua Ji in Pharmaceutical Chemistry

Introduction

Wenhua Ji is a notable inventor based in Shanghai, China. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds with therapeutic applications. His work focuses on creating effective medications with minimal side effects.

Latest Patents

Wenhua Ji holds a patent for "Aralkyl piperidine derivatives and their uses as antalgic or ataractic agent." This invention relates to aralkyl piperidine derivatives, compositions containing these compounds, and their applications in preparing antalgic or ataractic medicaments. The derivatives are characterized as a free base of the compound represented by a specific formula or a salt thereof. Pharmacological experiments indicate that these derivatives exhibit favorable antalgic and ataractic activity while maintaining low side effects. He has 1 patent to his name.

Career Highlights

Throughout his career, Wenhua Ji has worked with prominent organizations in the pharmaceutical industry. Notably, he has been associated with Nhwa Pharmaceutical Corporation and the Shanghai Institute of Pharmaceutical Industry. His experience in these institutions has allowed him to contribute to various innovative projects and research initiatives.

Collaborations

Wenhua Ji has collaborated with several professionals in his field, including Jianqi Li and Guan Zhong Wang. These collaborations have fostered a productive environment for research and development, leading to advancements in pharmaceutical sciences.

Conclusion

Wenhua Ji's contributions to pharmaceutical chemistry, particularly through his innovative patent, highlight his commitment to improving medication efficacy and safety. His work continues to influence the development of new therapeutic agents.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…